Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration

This publication has 13 references indexed in Scilit:

• Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
  Nature Medicine, 1996
• Quantitation of Phosphorothioate Oligonucleotides in Human Plasma
  Analytical Biochemistry, 1996
• Interactions of Phosphodiester and Phosphorothioate Oligonucleotides with Intestinal Epithelial Caco-2 Cells
  Pharmaceutical Research, 1996
• Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1
  Biochemical Pharmacology, 1995
• Pharmacokinetics of Antisense Oligonucleotides
  Clinical Pharmacokinetics, 1995
• Tritium labeling of antisense oligonucleotides by exchange with tritiated water
  Nucleic Acids Research, 1993
• Antisense oligonucleotides as antiviral agents
  Trends in Biotechnology, 1992
• Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice
  Biopharmaceutics & Drug Disposition, 1992
• Specific regulation of gene expression by antisense, sense and antigene nucleic acids
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1990
• Inhibition of deoxyribonucleases by phosphorothioate groups in oligodeoxyribonucleotides
  Nucleic Acids Research, 1988